pI: 6.6742 |
Length (AA): 355 |
MW (Da): 41252 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 9
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128504)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G07727 | cytochrome b |
Arabidopsis thaliana | ArthMp020 | apocytochrome B |
Arabidopsis thaliana | ArthCp053 | cytochrome b6 |
Babesia bovis | BBOV_VI000060 | cytochrome b |
Dictyostelium discoideum | DidioMp12 | cytochrome b |
Echinococcus granulosus | EgrG_900000100 | cytochrome B |
Homo sapiens | 4519 | cytochrome b |
Mycobacterium leprae | ML0879c | Probable Ubiquinol-cytochrome C reductase QcrB (cytochrome B subunit) |
Mus musculus | 17711 | cytochrome b |
Mycobacterium tuberculosis | Rv2196 | Probable ubiquinol-cytochrome C reductase QcrB (cytochrome B subunit) |
Mycobacterium ulcerans | MUL_3553 | ubiquinol-cytochrome C reductase QcrB |
Oryza sativa | 6450178 | apocytochrome b |
Oryza sativa | 3131403 | cytochrome b6 |
Onchocerca volvulus | OVOC10402 |
|
Plasmodium berghei | PBANKA_MIT01900 | cytochrome b |
Plasmodium falciparum | mal_mito_3 | cytochrome b |
Plasmodium knowlesi | PKNH_MIT01900 | cytochrome b |
Plasmodium vivax | PVAD80_MIT0003 | cytochrome b |
Plasmodium yoelii | PY00780 | Cytochrome b, putative |
Plasmodium yoelii | PY00774 | Cytochrome b, putative |
Plasmodium yoelii | PY00148 | Cytochrome b, putative |
Saccharomyces cerevisiae | Q0105 | cytochrome b |
Saccharomyces cerevisiae | Q0120 | intron-encoded RNA maturase bI4 |
Schistosoma japonicum | Sjp_0314560 | ko:K00412 ubiquinol-cytochrome c reductase cytochrome b subunit, putative |
Schistosoma mansoni | Smp_190460 | cytochrome b |
Schmidtea mediterranea | mk4.075142.00 | |
Toxoplasma gondii | TGME49_322210 | apocytochrome b, putative |
Toxoplasma gondii | TGME49_322200 | apocytochrome b, putative |
Toxoplasma gondii | TGME49_330000 | cytochrome b |
Theileria parva | Tpmp3 | cytochrome b |
Wolbachia endosymbiont of Brugia malayi | Wbm0775 | cytochrome b subunit of the bc complex |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2230 | Mycobacterium tuberculosis | essential | nmpdr |
TGME49_330000 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_322200 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_322210 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Sus scrofa | Cytochrome b | Compounds | References |